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Curcumin is an active ingredient with multiple functions, but its application is often 
restricted due to its poor water solubility, weak stability, and consequently low bioac-
cessibility. Based on this, the aim of this work is to develop a new vehicle to overcome 
these restrictions. Here we developed a curcumin-loaded nanoemulsion and then cur-
cumin-loaded silica-lipid hybrid microparticles through emulsification and vacuum dry-
ing, respectively. The loading of curcumin in the nanoemulsion and microparticles was 
(0.30±0.02) and (0.67±0.02) %, respectively. FTIR and XRD analyses of microparticles re-
vealed that curcumin was encapsulated in porous, amorphous silica. In vitro antioxidant 
activities showed that the encapsulation would not affect the antioxidant activity of cur-
cumin. In vitro simulated digestion indicated that nanoemulsion and microparticles had 
higher curcumin bioaccessibility than the control group. The storage stability of micro-
particles remained the same during 6 weeks in the dark at 4, 25 and 40 °C. Moreover, the 
microparticles had a better chemical stability than nanoemulsion under the light. The cell 
viability was over 80 % when the concentration of nanocarriers was less than 45 μg/mL. 
Hence, the microparticles could be a promising means to load curcumin and improve its 
solubility, light stability and bioaccessibility. 
Key words: curcumin, silica-lipid hybrid microparticles, antioxidant activity, bioaccessi-
bility, storage stability
INTRODUCTION
Curcumin is extracted from the rhizome of Curcuma longa, which has extensive phar-
macological and biological activities. In traditional medicine, curcumin has been valua-
ble in the treatment of various inflammation and other diseases for centuries (1). In recent 
years, a number of researchers have focused on curcumin and it has been well-document-
ed that curcumin possesses antioxidant, antimicrobial, anti-inflammatory and anticancer 
activities (2-4). Many reports have confirmed the potential of curcumin in the treatment 
of diabetes, rheumatoid arthritis, neurodegenerative diseases and cardiovascular diseas-
es (5-7). Furthermore, curcumin is approved as a Generally Recognized as Safe compound 
by the U.S. Food and Drug Administration (8), indicating the potential value in food and 
health care products because of its high security and biological activities.
Despite a variety of advantages, practical applications of curcumin are difficult be-
cause of its low water solubility, chemical instability and rapid metabolism in the gastro-
intestinal tract (8,9). These shortcomings ultimately lead to inadequate absorption and 
low bioavailability of curcumin. To solve these problems, many strategies have been de-
veloped which include chemical/physicochemical and physicomechanical methods (10). 
Among them, the lipid-based nanoparticle delivery systems are widely recognized due 
to their advantages and application prospect. The most common types of nanoparti-
cles include nanoemulsion, solid lipid nanoparticles, nanostructure lipid carriers, lipo-
somes, self-emulsifying drug delivery systems and so on. These nanoparticles can im-
prove the water solubility and bioaccessibility of curcumin (11). Besides, the nanocarriers 
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can encapsulate the curcumin molecules inside the cavities 
to protect curcumin from degradation and improve stability 
(12). Several studies show that the nanocurcumin has high-
er antioxidant and antimicrobial activities than raw curcum-
in (13,14). Furthermore, other activities of curcumin such as 
anticancer activity should not be affected. Researchers have 
found that liposomal curcumin could suppress the growth 
of pancreatic carcinoma and demonstrated antiangiogenic 
effects in vivo (15). Another research reveals that curcumin in 
solid lipid nanoparticles has xenograft-targeting effect and 
enhances the tumour inhibition efficiency significantly from 
19.5 to 69.3 % (16). These results indicate that the activity of 
nanocurcumin is tantamount to or better than raw curcumin.
Although these lipid-based nanoparticles have many ad-
vantages, they still face the challenges of physical stability 
and long-term storage stability. Solidification of liquid for-
mulation, such as dry emulsion, is considered a promising ap-
proach to solve these problems, which can improve the phys-
icochemical stability during long-term storage. Spray drying 
(17), lyophilisation (18), vacuum drying (19) and physical ad-
sorption (20) are the common solidification methods to elim-
inate the water phase from the liquid emulsion. Silica-lipid 
hybrid (SLH) microparticles are a kind of solid system based 
on silica particles and oil-in-water emulsion, which were re-
ported for the first time by Simovic et al. (21) and Tan et al. 
(22). The researches show that the SLH microparticles signifi-
cantly improve the solubility and stability of the water-insol-
uble drugs, and also enhance the oral absorption of drugs in 
experimental animals by simulating food effects (21-23). In 
another study (24), researchers found that the ibuprofen in 
SLH microparticles prepared by spray drying has higher sol-
ubility than the control group during a two-step dissolution 
and its bioavailability increased nearly 1.95-fold compared 
to the commercial tablets in clinical trials. Furthermore, the 
safety assessments reveal negligible acute side effects asso-
ciated with the blank and ibuprofen in SLH formulation (24). 
These results indicate that microparticles are effective and 
are safe for oral consumption, which is a promising method 
to improve the oral absorption of water-insoluble substance.
Various methods have been developed to improve the 
water solubility and bioavailability of curcumin in recent 
years, but there is little research of the effect of curcum-
in-loaded silica-lipid hybrid microparticles. In the current 
study, curcumin nanoemulsion was developed and the op-
timum formulation was selected through orthogonal exper-
iment. Then the microparticles were prepared with nano-
emulsion in a two-step process: production of silica-stabilised 
nanoemulsion and vacuum drying. The physicochemical 
properties, antioxidant ability, bioaccessibility, lipid diges-
tion property, and storage stability of the two samples were 
examined to investigate the similarities and differences be-
tween the microparticles and nanoemulsion. This investiga-
tion will provide a new perspective to solve the problems of 
curcumin and promote its application in more fields.
MATERIALS AND METHODS
Materials
Curcumin (95 %) was purchased from Sciphar Natural 
Products Co. Ltd. (Shaanxi, PR China). Octyl and decyl glyc-
erate (ODO) was obtained from Henan Zhengtong Food 
Technology Co. Ltd. (Henan, PR China). Tween 80 and Tween 
60 were provided by Guangzhou Runhua Chemical Co. Ltd. 
(Guangzhou, PR China). Phosphatidylcholine 60 (PC 60) was 
produced by Aikang Fine Chemical Co. Ltd. (Shanghai, PR Chi-
na). Hydrophilic fumed silica (Aerosil 380) was provided by 
Evonik Degussa (Essen, Germany). Povidone K30 (PVP (poly- 
vinylpyrrolidone) K30) was purchased from Star-Tech & JRS 
Specialty Products Co. Ltd. (Chongqing, PR China). Carboxy- 
methylcellulose sodium (CMC-Na) was obtained from Yuhe 
Food Additive Co. Ltd. (Zhengzhou, China). All the ingredients 
were of food grade.
The 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical was 
provided by Tokyo Chemical Industry Co. Ltd. (Tokyo, Japan), 
and 1,1,3,3-tetraethoxypropane (97 %) was purchased from 
Shanghai Macklin Biochemical Co. Ltd. (Shanghai, PR Chi-
na). Phosphotungstic acid, potassium bromide (KBr), trichlo-
roacetic acid (TCA) and 2-thiobarbituric acid (TBA) (≥98.5 %) 
were from Sinopharm Chemical Reagent Co. Ltd. (Shanghai, 
PR China). Pepsin, pancreatin and bile extract were from Sig-
ma-Aldrich, Merck (St. Louis, MO, USA). DMEM, fetal bovine se-
rum (FBS) and penicillin-streptomycin were purchased from 
Cellmax Cell Technology Co. Ltd. (Beijing, PR China). All other 
chemicals used were of analytical grade without further pu-
rification.
Preparation of curcumin nanoemulsion
Several mass fractions of Tween 80 (2.0–5.0 %), Tween 60 
(2.0–5.0 %) and PC 60 (2.0–5.0 %) were dissolved in 10 % ODO 
at 70 °C, followed by the addition of 0.3 % curcumin raw ma-
terial. PVP K30 0.6–1.2 % was added to the oil phase after cur-
cumin was completely dissolved. Then, Milli-Q water (Arium 
pro Basic, Sartorius, Goettingen, Germany) (73.5–83.1 %) was 
added to the oil mixture as the continuous phase. The mix-
ture was stirred for 10 min to form oil in water (o/w) emulsion.
Optimisation of curcumin nanoemulsion
The composition of curcumin nanoemulsion was opti-
mized by orthogonal experiment design with 5 factors (A-E) 
at 4 levels respectively: A=temperature (25, 40, 55 and 70 °C) 
of the preparation, and the mass fractions of B=Tween 80 (2, 3, 
4 and 5 %), C=Tween 60 (2, 3, 4 and 5 %), D=PC 60 (2, 3, 4 and 
5 %) and E=PVP K30 (0.6, 0.8, 1.0 and 1.2 %). Emulsion stability 
index (ESI) was chosen as evaluation index (25). The emulsion 
was stored at room temperature for 48 h after preparation, and 
then the data were measured to calculate the ESI as follows:
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where hC is the height of creamed phase, hE is the total height 
of the emulsion and hS is the height of sedimentation phase. 
Preparation of curcumin silica-lipid hybrid microparticles
According to the method of Tan et al. (22), the micropar-
ticles were prepared using a two-step process: the produc-
tion of silica-stabilised nanoemulsion and vacuum drying. 
Curcumin nanoemulsion was prepared as described in the 
section Preparation of curcumin nanoemulsion. The silica was 
added into o/w nanoemulsion in different silica-to-lipid ra-
tio by stirring constantly. The silica-stabilised emulsion was 
then vacuum-dried (DZF-6090; Jinghong, Shanghai, PR Chi-
na) under a pressure of 100 Pa at 50 °C to form solid powder. 
Drying lasted 4 h. Different silica-to-lipid mass ratios (1:1, 1:2 
and 1:3) were chosen to explore the effect of different addi-
tions on the formulation.
Morphological analysis
Transmission electron microscopy
The morphological characteristics of curcumin nano-
emulsion were studied by transmission electron microscope 
(TEM model JEM-2100; JEOL, Tokyo, Japan). The diluted nano-
emulsion sample was dropped onto carbon-coated grids and 
then negatively stained with 2 % (m/V) phosphotungstic acid. 
Subsequently, the excess liquid was wiped dry by filter paper 
and the sample was dried at room temperature.
Scanning electron microscopy 
The shape and surface characteristics of hydrophilic 
fumed silica having a specific surface area of 380 m²/g (Aero-
sil 380) and curcumin silica-lipid hybrid microparticles were 
explored by scanning electron microscope (SEM model Ultra 
Plus; Zeiss, Jena, Germany). The powder sample was fixed on 
a slide using double-sided adhesive tape and the character-
ized by a secondary electron detector.
Measurements of particle size and polydispersity index
The average redispersed particle sizes and polydispersity 
index (PDI) of the formulations were investigated by dynamic 
light scattering (DLS) technique (Zetasizer Nano ZS 90; Mal-
vern Panalytical Ltd, Malvern, UK) at a fixed scattering an-
gle of 90° and room temperature. Before measurement, 0.05 
g curcumin nanoemulsion or silica-lipid hybrid microparti-
cles were dispersed in 10 g Milli-Q water (Arium pro Basic, 
Sartorius). The aqueous dispersion was centrifuged (TGL-16; 
Xiangyi, Changsha, PR China) at 633×g for 10 min in order to 
precipitate the silica microparticles. Each sample was meas-
ured three times.
Loading of curcumin
The loading of curcumin in nanoemulsion and micropar-
ticles was measured by UV/Vis spectrophotometer (755B; 
Jinghua, Shanghai, PR China) at the wavelength of 425 nm. 
A mass of 0.1 g nanoemulsion or microparticles was mixed 
with 9.9 g ethanol to extract the curcumin from the formula-
tions. The ethanol extractions of curcumin were diluted 100 
times and centrifuged (TGL-16; Xiangyi) at 5595×g for 10 min 
before measurement. Curcumin loading was calculated by 
the following formula:















The samples were characterized by X-ray diffraction in-
strument (D8 Discover; Bruker GmbH, Mannheim, Germany) 
with CuKα radiation at 30 mA and 40 kV. The diffraction pat-
tern of Aerosil 380, curcumin silica-lipid hybrid microparti-
cles, and the physical mixture of curcumin and Aerosil 380 
was measured over a 2θ range of 5–60°. The scanning speed 
was 0.15 s/step with a step size of 0.02°.
Fourier transform infrared spectroscopy 
Infrared spectra of curcumin, blank silica-lipid hybrid mi-
croparticles, curcumin silica-lipid hybrid microparticles, and 
the physical mixture of curcumin and blank microparticles 
(curcumin content was the same as microparticles) were in-
vestigated by FTIR spectrophotometer (Nicolet 6700; Thermo 
Scientific, Waltham, MA, USA). The samples were mixed sep-
arately with potassium bromide and ground into fine powder. 
The mixture was processed into a tablet by electric tablet press 
(DY-30; Keqi, Shanghai, PR China) under a force of 25 MPa for 
10 s, and then analyzed in the range of 4000–400 cm–1.
In vitro antioxidant activity
DPPH scavenging activity
A volume of 100 μL of nanoemulsion and silica-lipid hy-
brid microparticles in ethanol (100 μL of ethanol as blank con-
trol group) with various mass fractions of curcumin were add-
ed to 3.9 mL DPPH ethanol solution, and then mixed evenly. 
The reaction was performed at ambient temperature in the 
dark. After 30 min of reaction, the absorbance of the mix-
ture was measured at 517 nm by UV/Vis spectrophotometer 
(755B; Jinghua, Shanghai, PR China). The antioxidant activity 
was calculated as follows:












÷ ×1 100  /3/
Anti-lipid peroxidation effects
Different concentrations of curcumin nanoemulsion 
and silica-lipid hybrid microparticles in Milli-Q water (Ari-
um pro Basic, Sartorius) were prepared. A volume of 0.5 mL 
of the sample was mixed with 1 mL of 1 % (m/V) soybean 
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phospholipid solution (0.5 mL of Milli-Q water as blank), 1 mL 
of 0.2 M (pH=7.4) phosphate buffer solution (PBS) and 1 mL 
of 5 mM FeCl2 in the tubes. The mixtures were incubated at 
37 °C for 60 min in the dark. Afterwards, 3 mL of TBA-TCA-HCl 
(containing 0.025 M thiobarbituric acid (TBA), 0.92 M TCA and 
0.58 M HCl) were added to the mixtures to stop the reaction. 
The tubes were placed at 95 °C for 15 min then cooled in an 
ice bath. The supernatant was collected after centrifugation 
(TGL-16; Xiangyi) at 685×g for 10 min and the absorbance was 
measured at 532 nm. Thiobarbituric acid reactive substances 
(TBARS) inhibition rate was calculated as follows:












In vitro simulation of digestion 
A two-step experiment was performed to simulate the 
gastric and small intestinal digestion of curcumin nanoemul-
sion and silica-lipid hybrid microparticles. Unformulated cur-
cumin was suspended in 0.5 % (m/V) CMC-Na solution as a 
control group (26). The experiment was done according to 
Huang et al. (27) with some modifications. 
To test simulated gastric digestion, simulated gastric flu-
id (SGF) was prepared by adding 7 mL HCl (36.5 %) and 2 g 
NaCl to 1 L Milli-Q water (Arium pro Basic, Sartorius), and then 
adjusting the pH to 1.2 with 1.0 M HCl. A volume of 10 mL 
of nanoemulsion diluent, aqueous dispersion of microparti-
cles and curcumin CMC-Na suspension containing 1 mg/mL 
of curcumin was mixed with 10 mL of SGF, respectively. The 
mixture was incubated at 37 °C for 2 h with agitation at 100 
rpm (EMS-30; Qianyue, Shanghai, PR China) after 32 mg of 
pepsin were added to it. 
To test simulated intestinal digestion, 0.05 M potassium 
dihydrogen phosphate solution served as simulated intesti-
nal fluid (SIF). Curcumin encapsulated in silica nanoparticles 
stabilised Pickering emulsion during storage and simulated 
digestion. The pH of the gastric phase was adjusted to 7.0 af-
ter simulated gastric digestion. Later, 10 mL of SIF contain-
ing 47.6 mg of pancreatin and 51.6 mg of bile extract were 
added to the mixture and incubated at 37 °C. At this point, 
the pH-stat titration served to maintain the pH of digestive 
juice at 7.0 by adding 0.1 M NaOH dropwise. The volume of 
NaOH was recorded at different time points during 2 h. The 
released free fatty acids (FFA) were calculated according to 
the following equation (11):














where VNaOH is the total volume of NaOH (mL) used to neutral-
ize the released FFA, cNaOH=0.1 M is the concentration of NaOH 
in the burette, Mlipid is the molecular mass of the oil in the for-
mula (g/mol), mlipid is the total mass (g) of lipid in the digestive 
juice. The particle size of the supernatant of the mixture was 
measured after each phase. 
The in vitro bioaccessibility of curcumin was measured 
after simulated digestion. The digestive solution was cen-
trifuged (TGL-16; Xiangyi) at 5595×g for 10 min and separat-
ed into two parts: one was the supernatant containing the 
mixed micelles, the other was the opaque sediment phase. 
The amount of curcumin in the supernatant was determined 
and the bioaccessibility was calculated as follows:
 Bioaccessibilit
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Storage stability
Curcumin nanoemulsion and silica-lipid hybrid micropar-
ticles were stored at 4, 25 and 40 °C (in the dark) and 25 °C un-
der light for 6 weeks. Curcumin content was measured every 
week of the storage (ethanol solution of curcumin was used 
as a control). Also, the dispersion of particle size and appear-
ance of microparticles were inspected. 
Cell toxicity evaluation
L929 murine fibroblast cell line, purchased from the 
Type Culture Collection of the Chinese Academy of Scienc-
es (Shanghai, PR China) was chosen for cell studies. Cells 
were cultured in DMEM medium supplemented with 10 % 
FBS and 1 % penicillin-streptomycin at 37 °C in a 5 % CO2 in-
cubator.
For the assessment of cell viability, the cells were plat-
ed in 96-well plates (100 μL/well) at a density of 104 cells/
mL and cultured for 12 h (blank group was only given an 
equal volume of cell culture medium without cells). The 
curcumin nanoemulsion, blank nanoemulsion, silica-lipid 
hybrid microparticles and blank particles were diluted to 
various concentrations (4, 8, 12, 20, 30, 45, 60, 80, 100 and 
150 μg/mL) with culture medium and then added to 96-well 
plates (Goyoobiotech, Nanjing, PR China) (100 μL/well). Con-
trol and blank groups received 100 μL cell culture medium. 
The medium was removed and the cells were washed with 
PBS after 24 h of treatment. Then, 200 μL cell counting kit-
8 (CCK-8; Goyoobiotech) solution (10 % in culture medium) 
were added to the wells for further incubation for 1.5 h, and 
then the absorbance (A) was recorded by a microplate read-




All the experiments were done in triplicate. Results were 
expressed as mean value and standard deviation (mean±S.D.). 
The results were analyzed by ANOVA and t-test. Data were 
considered significant at p<0.05.
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The sample with 1:2 ratio resulted in yellow agglomerated 
mass with poor powder mobility. The microparticles with sili-
ca-to-lipid mass ratio 1:1 formed dry and free flowing powder 
which was up to the standard. 
Physicochemical characterization of nanoemulsion  
and microparticles
Table 2 shows the particle size (redispersed particle size) 
and PDI of curcumin microparticles. The particle size of the na-
noemulsion and microparticles was further analyzed by TEM. 
The hydrophobic tails of emulsifier molecules attach to hy-
drophobic core formed by the oil phase, while the hydrophilic 
heads protrude into aqueous phase, forming small spheroid 
particles dispersed in the aqueous phase. The spherical struc-
ture of nanoemulsion droplets is observable in Fig. 1a. The 
RESULTS AND DISCUSSION
Results of orthogonal experiment
Orthogonal experiment is a method to analyze the correla-
tions of variables at different levels by an orthogonal table and 
statistical analysis, which can be used for the optimization of 
multiple formulae (28,29). The stability of o/w emulsion is closely 
related to many factors such as the preparation conditions and 
formulation composition. An orthogonal experiment was de-
signed to optimize the formulation of curcumin nanoemulsion 
by testing the effects of preparation temperature and emulsifier 
mass fraction on the ESI. The results and analysis of orthogonal 
experiment are shown in Table 1. The sequence of effects on ESI 
to evaluate the preparation was: A (temperature)>D (PC 60)>E 
(PVP K30)>C (Tween 60)>B (Tween 80), which indicated that the 
temperature had significant effect on the stability of the formu-
la and Tween 80 had little influence on the ESI of the o/w emul-
sion. Comprehensively considering the performance of each lev-
el, the optimum preparation conditions were A4B4C3D2E1. Based 
on the results, the optimal conditions for the preparation of na-
noemulsion were ODO 10 %, curcumin 0.3 %, Tween 80 5 %, 
Tween 60 4 %, PC 60 3 %, PVP K30 0.6 % and Milli-Q water 77.1 
%, and preparation temperature 70 °C.
Curcumin silica-lipid hybrid microparticle formation 
Microparticles with different silica-to-lipid mass ratios (1:1, 
1:2 and 1:3) were prepared by vacuum drying. The sample with 
silica-to-lipid mass ratio 1:3 appeared as a thick, oily mixture af-
ter vacuum drying and there was no powder product formed. 
Table 1. The results of orthogonal experiment
No.
Factor
Cur/% ODO/% Water/% Score
A/°C B/% C/% D/% E/%
1 25 2.0 2.0 2.0 0.6 0.3 10 83.1 33.93
2 25 3.0 3.0 3.0 0.8 0.3 10 79.9 31.30
3 25 4.0 4.0 4.0 1.0 0.3 10 76.7 30.97
4 25 5.0 5.0 5.0 1.2 0.3 10 73.5 32.77
5 40 3.0 4.0 5.0 0.6 0.3 10 77.1 31.50
6 40 2.0 5.0 4.0 0.8 0.3 10 77.9 30.90
7 40 5.0 2.0 3.0 1.0 0.3 10 78.7 35.47
8 40 4.0 3.0 2.0 1.2 0.3 10 79.5 46.97
9 55 4.0 5.0 3.0 0.6 0.3 10 77.1 65.10
10 55 5.0 4.0 2.0 0.8 0.3 10 77.9 59.23
11 55 2.0 3.0 5.0 1.0 0.3 10 78.7 19.39
12 55 3.0 2.0 4.0 1.2 0.3 10 79.5 33.17
13 70 5.0 3.0 4.0 0.6 0.3 10 77.1 78.33
14 70 4.0 2.0 5.0 0.8 0.3 10 77.9 27.53
15 70 3.0 5.0 2.0 1.0 0.3 10 78.7 58.40
16 70 2.0 4.0 3.0 1.2 0.3 10 79.5 70.07
k1 32.24 38.57 32.52 49.63 52.22
k2 36.21 38.59 44.00 50.48 37.24
k3 44.22 42.64 47.94 49.26 36.06
k4 58.58 51.45 46.79 27.80 45.74
R 26.37 12.88 15.42 22.68 16.16
A=temperature (° C) of the preparation, B, C, D, E=mass fractions (%) of Tween 80, Tween 60, PC 60 and PVP K30, respectively, and ODO=octyl 
and decyl glycerate 
Table 2. Appearance, size of dispersed particles and polydispersity 









2 Yellow powder 178.0±1.8 0.26±0.02
4 Yellow powder 178.0±2.0 0.26±0.02
6 Yellow powder 178.8±1.3 0.25±0.03
25
2 Yellow powder 179.4±1.6 0.26±0.01
4 Yellow powder 179.27±0.09 0.26±0.01
6 Yellow powder 181.5±2.1 0.26±0.02
40
2 Yellow powder 180.7±2.3 0.26±0.01
4 Yellow powder 179.0±3.0 0.263±0.009
6 Yellow powder 179.3±2.0 0.27±0.01
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dynamic light scattering test showed that the particle size 
of nanoemulsion was (40.5±2.4) nm, which was substantiat-
ed by the diameter of particles in the TEM. PDI of nanoemul-
sion and microparticles was (0.16±0.02) and (0.26±0.02), re-
spectively. The particle size and PDI of nanoemulsion were 
significantly smaller ((177.2±3.3) nm) than of microparticles. 
This could be ascribed to the oil droplet interfaces absorbed 
by tiny silica particles, leading to an increase in the parti-
cle size of the redispersed microparticles (30). The SEM im-
ages of Aerosil 380 and microparticles are shown in Fig. 1b 
and Fig. 1c, respectively. In a previous study (31), Aerosil 380 
consisted of 7-nm primary particles, which indicates a po-
rous internal structure with pore sizes ranging from 25 to 
100 nm. The SEM image (Fig. 1b) showed a loose, porous 
and nearly spherical shape which gave the particles highly 
specific surface area and strong adsorption ability. Never-
theless, the microparticles (Fig. 1c) lost these features and 
had a rough surface, with microparticles formed when the 
oil phase was adsorbed onto the porous silica matrices. The 
results were consistent with the findings of Simovic et al. (21) 
where droplets were uniformly distributed and absorbed 
onto the surface of silica instead of forming a continuous 
film. In other study, Tan et al. (22) proposed that there could 
be redistribution and self-assembly of the Aerosil 380 par-
ticles from the continuous phase to the droplet surface and 
the inner wick during dehydration. The curcumin contents 
of nanoemulsion and microparticles were (0.30±0.02) and 
(0.67±0.02) %, respectively, indicating that curcumin loading 
increased after solidification.
XRD spectra
Crystalline or amorphous phase of curcumin in the sili-
ca-lipid hybrid microparticles was investigated by XRD analy-
sis. The XRD spectra of curcumin, Aerosil 380, physical mixture 
of curcumin and Aerosil 380 and curcurmin microparticles are 
shown in Fig. 2a. Several sharp peaks in the diffractogram of 
the physical mixture of curcumin and Aerosil 380 indicated 
that curcumin existed in crystalline form. In contrast, the XRD 
spectrum of microparticles was similar to that of Aerosil 380 
particles and there was no characteristic peak observed. The 
results suggested that curcumin was in an XRD-amorphous 
state in the microparticles.
FTIR spectra
FTIR was chosen to investigate the interactions between 
curcumin and excipients in the solid state. The FTIR spectra 
of curcumin, blank silica-lipid hybrid microparticles, phys-
ical mixture of curcumin and curcumin silica-lipid hybrid 
microparticles are shown in Fig. 2b. A characteristic peak 
observed at 3508 cm–1 in the spectra of curcumin powder 
corresponded to the O–H stretching vibration, which was 
different from the broad peak of amorphous curcumin in 
the study of Li et al. (32). This phenomenon suggested a dif-
ferent molecular environment of hydroxyl groups between 
crystalline curcumin and amorphous curcumin. The peak 
at 1627 cm–1 was related to the C=O group and the band 
at 1509 cm–1 indicated the presence of C=C group. Mean-
while, these characteristic peaks still existed in the spectra 
of physical mixture, indicating no interaction between the 
curcumin and blank microparticles. However, the charac-
teristic peaks disappeared in curcumin microparticles and 
the spectrum was similar to that of blank microparticles. 
Therefore, the results indicate that curcumin was incorpo-
rated in Aerosil 380 and remained in dissolved state in the 
microparticles (33,34). 
Fig. 1. Transmission electron microscopic image of: a) curcumin na-
noemulsion, and scanning electron microscopic images of: b) hydro-
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In vitro antioxidant activity of curcumin nanoemulsion and 
microparticles
DPPH free radical scavenging assay 
DPPH is a stable radical which has been extensively ap-
plied in the analysis of antioxidant activity. Generally, DPPH 
signals decrease when the odd electron of DPPH radical be-
comes paired with hydrogen from a free radical scavenging 
antioxidant to form the reduced DPPH-H (35). In this study, 
the DPPH assay was used to explore the free radical scav-
enging activity of curcumin nanoemulsion and microparti-
cles. According to the results in Fig. 3a, the nanoemulsion 
and microparticles showed a higher DPPH scavenging activ-
ity than curcumin ethanol solution. The DPPH scavenging ac-
tivity of nanoemulsion was 87.98 and of microparticles 87.06 
%, which was higher than of control (81.17 %) when the con-
centration was 1 mg/mL. It can be postulated that the na-
noparticles protected curcumin from degradation and thus 
increased its antioxidant activity. In addition, the radical scav-
enging activity of microparticles was slightly lower than that 
of nanoemulsion when the concentration was lower than 1 
mg/mL. Sari et al. (36) concluded that the encapsulation of 
silica not only reduces the degradation of curcumin but may 
also preserve its antioxidant activity. Hence, this result indi-
cates that the free radical scavenging activity of curcumin 
was not affected by the encapsulation.
Anti-lipid peroxidation
Lipid peroxidation is often responsible for biological dam-
age, particularly the biological membrane of the brain or liver 
(37). Generally, malondialdehyde is one of the major products 
of lipid peroxidation, whose levels can be spectrophotometri-
cally determined by forming a complex with the 2-thiobarbi-
turic acid called TBA reactive substances (TBARS). The TBARS 
inhibition by curcumin nanoemulsion, silica-lipid hybrid mi-
croparticles and curcumin ethanol solution is shown in Fig. 
3b. It was observed that the anti-lipid peroxidation capacities 
a)
b)
Fig. 2. The spectra of: a) X-ray diffraction of curcumin, Aerosil 380, 
physical mixture of curcumin and Aerosil 380, and curcumin silica-li-
pid hybrid microparticles (Cur-SLH), and b) FTIR of curcumin, blank 
silica-lipid hybrid microparticles (Blank SLH), physical mixture of cur-













































Fig. 3. Results of: a) DPPH scavenging activity of curcumin ethanol 
solution (Cur-EtOH), curcumin nanoemulsion (Cur-NE) and curcum-
in silica-lipid hybrid microparticles (Cur-SLH). Results are shown as 
mean value±S.D. (N=3), and b) TBARS inhibition by Cur-EtOH, Cur-NE 
and Cur-SLH. Results are shown as mean value±S.D. (N=3)
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of nanoemulsion and microparticles increased in a dose-de-
pendent manner, and the inhibition rate was over 50 % at the 
concentration of 100 μg/mL. However, the TBARS inhibition 
by microparticles was slightly lower than of curcumin ethanol 
solution, which can be explained as the result of the slow re-
lease of curcumin from Aerosil 380.
Results of in vitro simulation of digestion study
A two-step experiment was used to investigate the simulat-
ed digestion of curcumin nanoemulsion and silica-lipid hybrid 
microparticles. The particle sizes of digestive juice were meas-
ured after each digestion phase by DLS technique. The chang-
es in the particle size are observable in Fig. 4a. Nanoemulsion 
and microparticles before digestion had mean particle size of 
(40.5±2.4) and (177.2±3.3) nm, respectively. After gastric diges-
tion, there was not much change in the particle size of the two 
samples. This result indicates that the structures of the two sam-
ples remained stable and the oil droplets were not destroyed 
during gastric digestion. However, after 2 h of intestinal diges-
tion, the particle sizes of nanoemulsion and microparticles in-
creased significantly to (100.0±2.3) and (822.0±4.7) nm, re-
spectively. The augmentation of particle sizes suggested that 
droplets were destabilized in the process of simulated intesti-
nal digestion. Previous research showed that bile salts can take 
the place of surfactant molecules from the oil-water interface, 
facilitate the binding of pancreatic enzymes to the oil-water in-
terfacial layer and promote the lipid digestion, leading to the 
destabilization of emulsion (38,39). The complex reactions that 
occurred in the intestine resulted in the formation of mixed mi-
celles with the ability to transport the encapsulated compo-
nents to the surface of the enterocytes and enhance the ab-
sorption of nutrients (40).
During the intestinal digestion, oil droplets are broken down 
into free fatty acids and monoglycerides so the bioactive mole-
cules can be released (41). In this study, the degree of lipid diges-
tion from the nanoemulsion and microparticles was measured 
by instilling 0.1 M NaOH into digestive juice to neutralize free 
fatty acids. As shown in Fig. 4b, there was a rapid increase in the 
rate of free fatty acid release from nanoemulsion and microparti-
cles in the first 30 min, followed by a more gradual increase from 
30 to 120 min. However, there were some differences in the rate 
and extent of digestion between nanoemulsion and micropar-
ticles. The initial digestion rate of nanoemulsion was faster than 
that of microparticles, which can be attributed to the difference 
in the droplet size. A number of studies have found that the re-
lease rate of free fatty acids increases as the lipid droplet size de-
creases (42). Due to large specific surface area of small droplets, 
their contact with lipase molecule increased (43). Moreover, the 
final amount of free fatty acids released from the microparticles 
was lower than from nanoemulsion, which indicated that the 
microparticles can inhibit the release of oil droplets. The possible 
reason was that the oil-water interface was adsorbed by silica 
particles which led to the inhibition of oil release (30).
Bioaccessibility is defined as the fraction of the active in-






























































Fig. 4. Results show: a) particle size of curcumin nanoemulsion (Cur-
-NE) and curcumin silica-lipid hybrid microparticles (Cur-SLH) before 
digestion in simulated gastric fluid (SGF) and simulated intestinal 
fluid (SIF). Results are shown as mean value±S.D. (N=3). Different 
symbols mean significant difference (p≤0.01), b) cumulative FFA re-
leased by Cur-NE and Cur-SLH during the simulated gastric digestion. 
Results are shown as mean value±S.D. (N=3), and c) bioaccessibility 
of curcumin from Cur-CMC-Na suspension (as a control group), Cur-
-NE and Cur-SLH after the simulated digestion. Results are shown as 
mean value±S.D. (N=3). ***Significantly different (p≤0.01) 
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gastrointestinal digestion, so it is considered as an estimable 
method of oral bioavailability (44). The bioaccessibility of the 
samples was measured at the end of simulated intestinal diges-
tion. As shown in Fig. 4c, there was a significant increase in bio-
accessibility of nanoemulsion and microparticles compared to 
curcumin CMC-Na suspension, indicating that nanocarriers can 
improve the bioavailability of curcumin. However, it was obvious 
from the results that the bioaccessibility of nanoemulsion was 
higher than that of microparticles. Similarly, the bioaccessibility 
of the free fatty acids increased with the increase of their release. 
The difference in curcumin bioaccessibility between nanoemul-
sion and microparticles may be due to two reasons. Lower re-
lease of free fatty acids resulted in more undigested lipids, which 
entrap curcumin. Furthermore, there were not enough mixed 
micelles to dissolve curcumin (45).
Storage stability of curcumin nanoemulsion  
and microparticles
Stability is an important factor in examining the quality 
of the system. In this study, the retention ratios of curcumin 
in nanoemulsion, silica-lipid hybrid microparticles and etha-
nol solution was measured during 6 weeks of storage at dif-
ferent temperatures to investigate the chemical stability of 
the three samples. Fig. 5a shows that the retention ratios of 
curcumin in the nanoemulsion did not change significantly 
during storage at 4 and 25 °C, and changed slightly at 40 °C. 
On the whole, the nanoemulsion maintained good chemical 
stability during 6 weeks of storage. The same result was also 
obtained with microparticles (Fig. 5b). However, the samples 
stored in light behaved differently from those in the dark (Fig. 
5c). During 6 weeks of storage, the curcumin retention ratios 
of nanoemulsion declined to 31.20 %, which suggested the 
formulation was unstable when exposed to light and should 
be stored in the dark. The retention ratio of microparticles 
also decreased and remained at 73.23 %. Even so, it was still 
clearly higher than that of nanoemulsion. This observation 
confirmed that solid preparations protected curcumin bet-
ter when exposed to light. The possible reason was that the 
curcumin was encapsulated in the pores of Aerosil 380, which 
could reduce the influence of light on curcumin (45). Table 2 
shows the dispersed particle size and appearance of curcum-
in microparticles during storage. The dispersed particle size 
and appearance have not changed significantly, which indi-
cates a good physical stability.
Cell toxicity evaluation of curcumin nanoemulsion and 
microparticles
Viability of L929 murine fibroblast cells was measured 
by CCK-8 assay and the results are in Fig. 6. The preliminary 
cell studies demonstrated that the blank carriers do not have 
negative effect on the cell viability, which indicated high safe-
ty of the excipients used in the formula. Curcumin nanocar-
riers deterred the cell viability in a dose-dependent manner. 










































































Fig. 5. Retention ratios of curcumin in: a) curcumin nanoemulsion 
(Cur-NE), b) curcumin silica-lipid hybrid microparticles (Cur-SLH) 
during storage for 6 weeks at 4, 25 and 40 °C in the dark, and c) cur-
cumin in ethanol solution (Cur-EtOH), Cur-NE and Cur-SLH during 
storage for 6 weeks at 25 °C under light. Results are shown as mean 
value±S.D. (N=3)
nanocarriers was less than 45 μg/mL. The viability dropped to 
less than 50 % when L929 murine fibroblast cells were treat-
ed with 150 μg/mL nanocarriers. The results indicate that cur-
cumin at a certain concentration had evident cytotoxicity. In 
addition, the same concentration of curcumin microparticles 
was less cytotoxic than nanoemulsion when the concentra-
tion was higher than 30 μg/mL, which was probably due to 
the incomplete release of curcumin in the solid preparation.
Y. MA et al.: Curcumin Silica-Lipid Hybrid Microparticles
July-September 2019 | Vol. 57 | No. 3328
CONCLUSIONS
In this study, curcumin-loaded oil in water nanoemulsion 
and curcumin silica-lipid hybrid microparticles were success-
fully optimized to improve the solubility and bioavailability of 
curcumin. Orthogonal experiment was used to obtain an opti-
mum emulsion composition. The microparticles were prepared 
using a two-step process, which showed good flow properties. 
XRD analysis suggested that curcumin was in XRD-amorphous 
instead of crystalline state in the microparticles. FTIR experi-
ment showed that curcumin was encapsulated in Aerosil 380 
and remained dissolved in the microparticles. In vitro antiox-
idant activity experiment confirmed that both formulations 
had good capacity for DPPH free radical scavenging and an-
ti-lipid peroxidation. Results of in vitro digestion showed that 
the product digestion occurred mainly in intestinal juice due 
to the effects of bile salts and pancreatic enzymes. Compared 
with nanoemulsion, the rate and extent of free fatty acid release 
were reduced when the lipid was incorporated with Aerosil 380, 
which was due to the restraint of microparticles on the lipolysis 
of oil droplets. Moreover, the bioaccessibility of curcumin from 
nanoemulsion and microparticles was significantly higher than 
from curcumin carboxymethylcellulose sodium suspensions, 
which indicated that curcumin-lipid complexes could enhance 
the absorption of curcumin. The two formulations could main-
tain good chemical stability for 6 weeks at different tempera-
tures in the dark and the microparticles protected curcumin 
better from degradation under light conditions. The curcumin 
carriers showed a low cell cytotoxicity when the concentration 
of curcumin was less than 45 μg/mL. It can be concluded that 
the solid preparation has better stability and is a promising ap-
proach to improve the bioavailability for curcumin.
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